Intradermal Tests With Drugs: An Approach to Standardization.

dc.contributor.authorBarbaud, Annick
dc.contributor.authorWeinborn, Marie
dc.contributor.authorGarvey, Lene Heise
dc.contributor.authorTesti, Sergio
dc.contributor.authorKvedariene, Violeta
dc.contributor.authorBavbek, Sevim
dc.contributor.authorMosbech, Holger
dc.contributor.authorGomes, Eva
dc.contributor.authorAberer, Werner
dc.contributor.authorElberink, Hanneke N G Oude
dc.contributor.authorTorres, Maria Jose
dc.contributor.authorPonvert, Claude
dc.contributor.authorAyav, C
dc.contributor.authorGooi, Jimmy
dc.contributor.authorBrockow, Knut
dc.date.accessioned2025-01-07T12:20:37Z
dc.date.available2025-01-07T12:20:37Z
dc.date.issued2020-05-15
dc.description.abstractBackground: Intradermal tests (IDTs) are performed and interpreted differently in drug allergy centers making valid comparison of results difficult. Objective: To reduce method-related and intercenter variability of IDTs by the introduction of a standardized method. Materials and methods: In 11 centers of the European Network for Drug Allergy, IDTs were prospectively performed with saline and with amoxicillin (20 mg/ml) using (1) the local method and (2) the standardized European Network in Drug Allergy (ENDA) method (0.02 ml). The diameters of the initial injection wheal (Wi) for the different volumes and sites injected obtained from each center were analyzed. Results: The most reproducible method was to fill a syringe with test solution, then expel the excess fluid to obtain exactly 0.02 ml. The median Wi diameter with 0.02 ml injection using the standardized method was 5 mm [range 2-10 mm; interquartile range (IQR) 5-5 mm; n = 1,096] for saline and 5 mm (range 2-9 mm; IQR = 4.5-5 mm; n = 240) for amoxicillin. IDT injection sites did not affect the Wi diameter. Training improved precision and reduced the variability of Wi diameters. Conclusion: Using the standardized IDT method described in this multicenter study helped to reduce variability, enabling more reliable comparison of results between individuals and centers.
dc.identifier.doi10.3389/fmed.2020.00156
dc.identifier.issn2296-858X
dc.identifier.pmcPMC7243670
dc.identifier.pmid32500075
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7243670/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fmed.2020.00156/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24485
dc.journal.titleFrontiers in medicine
dc.journal.titleabbreviationFront Med (Lausanne)
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.number156
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectamoxicillin
dc.subjectdrug allergy
dc.subjectintradermal test
dc.subjectspecificity of drug skin tests
dc.subjectstandardization
dc.titleIntradermal Tests With Drugs: An Approach to Standardization.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number7

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7243670.pdf
Size:
347.57 KB
Format:
Adobe Portable Document Format